SG11201401835VA - Ultra-concentrated rapid-acting insulin analogue formulations - Google Patents

Ultra-concentrated rapid-acting insulin analogue formulations

Info

Publication number
SG11201401835VA
SG11201401835VA SG11201401835VA SG11201401835VA SG11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA SG 11201401835V A SG11201401835V A SG 11201401835VA
Authority
SG
Singapore
Prior art keywords
ultra
acting insulin
insulin analogue
analogue formulations
concentrated
Prior art date
Application number
SG11201401835VA
Inventor
Michael Weiss
Original Assignee
Univ Case Western Reserve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201161552246P priority Critical
Application filed by Univ Case Western Reserve filed Critical Univ Case Western Reserve
Priority to PCT/US2012/062423 priority patent/WO2013063572A1/en
Publication of SG11201401835VA publication Critical patent/SG11201401835VA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
SG11201401835VA 2011-10-27 2012-10-29 Ultra-concentrated rapid-acting insulin analogue formulations SG11201401835VA (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201161552246P true 2011-10-27 2011-10-27
PCT/US2012/062423 WO2013063572A1 (en) 2011-10-27 2012-10-29 Ultra-concentrated rapid-acting insulin analogue formulations

Publications (1)

Publication Number Publication Date
SG11201401835VA true SG11201401835VA (en) 2014-09-26

Family

ID=48168643

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401835VA SG11201401835VA (en) 2011-10-27 2012-10-29 Ultra-concentrated rapid-acting insulin analogue formulations

Country Status (11)

Country Link
US (1) US9908925B2 (en)
EP (1) EP2771026A4 (en)
JP (1) JP2014533241A (en)
KR (1) KR20150021011A (en)
CN (1) CN104010652A (en)
AU (1) AU2012328407A1 (en)
BR (1) BR112014010139A2 (en)
IN (1) IN2014CN03888A (en)
NZ (1) NZ624493A (en)
SG (1) SG11201401835VA (en)
WO (1) WO2013063572A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015010194A2 (en) * 2012-11-05 2017-12-12 Univ Case Western Reserve nucleic acid sequence, single-stranded insulin analog and use thereof in the manufacture of a medicament for reducing blood sugar
WO2015106269A2 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
AR099569A1 (en) 2014-02-28 2016-08-03 Novo Nordisk As Insulin derivatives and medical uses of these
US20170304361A1 (en) * 2014-10-20 2017-10-26 Case Western Reserve University Halogenated insulin analogues of enhanced biological potency
WO2016105545A2 (en) * 2014-12-24 2016-06-30 Case Western Reserve University Insulin analogues with enhanced stabilized and reduced mitogenicity
JP2018531899A (en) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー/エス Novel insulin derivatives and their medical use
EP3341401A1 (en) 2015-08-25 2018-07-04 Novo Nordisk A/S Novel insulin derivatives and the medical uses hereof
AR106364A1 (en) 2015-08-25 2018-01-10 Novo Nordisk As Insulin derivatives and medical uses
WO2017070617A1 (en) * 2015-10-21 2017-04-27 Case Western Reserve University Diol-modified insulin analogues containing a glucose-regulated conformational switch

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
WO1990001038A1 (en) 1988-07-20 1990-02-08 Nordisk Gentofte A/S Human insulin analogs and preparations containing them
US5474978A (en) 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US20030104981A1 (en) * 1995-11-03 2003-06-05 Jelena Mandic Human insulin analogues
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations having improved stability
US7317000B2 (en) * 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
EP1453860A2 (en) 2001-12-02 2004-09-08 Novo Nordisk A/S Novel glucose-dependant insulins
CN1787833A (en) * 2003-03-11 2006-06-14 诺沃挪第克公司 Pharmaceutical preparations comprising acid-stabilised insulin
SE0401942D0 (en) 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
JP2008510692A (en) 2004-08-20 2008-04-10 ノボ ノルディスク アクティーゼルスカブNovo Nordisk Aktie Selsxab Pharmaceutically active insulin receptor modulatory molecules
WO2008043033A2 (en) * 2006-10-04 2008-04-10 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
MX338336B (en) 2007-11-20 2016-04-07 Ambrx Inc Modified insulin polypeptides and their uses.
NZ590792A (en) 2008-07-31 2012-12-21 Univ Case Western Reserve Halogen-stabilized insulin
KR20120129875A (en) 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 Insulin analogues with chlorinated amino acids
AU2009335712B2 (en) 2008-12-19 2015-09-17 Indiana University Research And Technology Corporation Insulin analogs

Also Published As

Publication number Publication date
US9908925B2 (en) 2018-03-06
JP2014533241A (en) 2014-12-11
US20140323398A1 (en) 2014-10-30
NZ624493A (en) 2016-02-26
EP2771026A4 (en) 2015-08-05
CN104010652A (en) 2014-08-27
KR20150021011A (en) 2015-02-27
IN2014CN03888A (en) 2015-10-16
WO2013063572A1 (en) 2013-05-02
BR112014010139A2 (en) 2017-04-25
EP2771026A1 (en) 2014-09-03
AU2012328407A1 (en) 2014-05-22

Similar Documents

Publication Publication Date Title
TWI561511B (en) Pesticidal compositions and processes related thereto
IL224904A (en) Compounds for use in pesticidal compositions
EP2775843A4 (en) Pesticidal compositions and processes related thereto
HK1201028A1 (en) Pesticidal compositions and processes related thereto
EP2649595A4 (en) Medication dispensing cart
ZA201403788B (en) Stable pesticidal compositions
AP3802A (en) Pesticidal compositions and processes related thereto
AP3864A (en) Pharmaceutical composition
IL254322D0 (en) Dental implant
AU2017202203A1 (en) Wheeled chair
IL223206A (en) Vaccine formulations
EP2782540A4 (en) Wheeled chair
ZA201400692B (en) Stabilized subtilisin composition
IL232053D0 (en) Antibody formulations
PL2793578T3 (en) N-arylamidine-substituted trifluoroethylsulfide derivatives as acaricides and insecticides
HK1198284A1 (en) Compositions comprising a shelf-life stability component
IL228721A (en) Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines and pharmaceutical compositions thereof
HK1200722A1 (en) Etanercept formulations stabilized with meglumine
IL229749D0 (en) Stable formulations of a hyaluronan-degrading enzyme
AP3447A (en) Pesticidal compositions and processes related thereto
ZA201106755B (en) Fast-acting insulin formulation
EP2547333A4 (en) Stable bortezomib formulations
TWI563077B (en) Cleaning formulations
IL225457D0 (en) Pharmaceutical composition
EP2692380A4 (en) Syringe